Antisense Therapeutics Limited is a limited by shares, listed public company, Australian public company. This corporation was registered on 2000-11-13 and was issued with the 095060745 ACN. Its Australian Business Number is 41095060745. Since 2000-11-30, the company is headquartered in VIC, post code 3142. Antisense Therapeutics Limited was registered for the GST on 2000-11-13. Antisense Therapeutics Limited has been using the Antisense Therapeutics Limited trading name since 2000-11-30 (it has to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2000-12-20.
| Status | From | To |
|---|---|---|
| Active | 2000/11/13 | current |
| Name | From | To |
|---|---|---|
| Antisense Therapeutics Limited | 2000/12/20 | current |
| Antisense Therapeutics Ltd | 2000/11/30 | 2000/12/20 |
| Name | From | To |
|---|---|---|
| Antisense Therapeutics Limited | 2000/11/30 | current |
| Location | From | To |
|---|---|---|
| VIC 3142 | 2000/11/30 | current |
| Status | From | To |
|---|---|---|
| Registered | 2000/11/13 | current |
Advertisements
General information:
| Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61K 38/00 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l) |
| Main group code: | 38 - medicinal preparations containing peptides (peptides containing beta-lactam rings a61k0031000000; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, a61k0031000000; ergoline-based peptides a61k0031480000; containing macromolecular compounds having statistically distributed amino acid units a61k0031740000; medicinal preparations containing antigens or antibodies a61k0039000000; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, a61k0047000000) |
IP Australia process information:
| Expiry date: | 2024/02/11 |
General information:
| Patent status: |
Filed The specification prior to acceptance and where the application has not lapsed |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61K 38/27 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l) |
| Main group code: | 38 - medicinal preparations containing peptides (peptides containing beta-lactam rings a61k0031000000; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, a61k0031000000; ergoline-based peptides a61k0031480000; containing macromolecular compounds having statistically distributed amino acid units a61k0031740000; medicinal preparations containing antigens or antibodies a61k0039000000; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, a61k0047000000) |
| Subgroup code: | 27 - growth hormone (gh) (somatotropin) |
IP Australia process information:
| Expiry date: | 2033/02/04 |
General information:
| Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61P 11/00 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | P - specific therapeutic activity of chemical compounds or medicinal preparations |
| Main group code: | 11 - drugs for disorders of the respiratory system |
IP Australia process information:
| Expiry date: | 2025/10/20 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.